Latest News

Read the latest news from 23Strands, media releases, journal articles and company announcements.

Cancer23

Application of 23Strands’ AI-powered Platform in Identifying Gene-Lists for Endometriosis

In recent research, the technical capability of wholly Australian-owned bioinformatics start-up, 23Strands, to decipher big data about genomics is revolutionising scientific research in women’s health. 23Strands’ work in genomics was linked with known molecular pathways for endometriosis to identify key genes associated with the disease.

Aug 18, 2023

Cancer23

Haemochromatosis Awareness Week

23Strands merges AI with whole genomic sequencing to create personalized treatments for genetic diseases, including haemochromatosis. They conduct thorough gene expression analyses, pinpointing potential targets for precision drug therapy and assessing chemotherapy responses. Their primary goal is addressing genetic diseases through personalized medicine.

Jun 5, 2023

Cancer23

23Strands in Support of White Shirt Day in the Fight against Ovarian Cancer

23Strands is standing in solidarity in the fight against ovarian cancer. Ovarian cancer remains one of the most fatal cancers affecting women. Globally, a woman or girl who is diagnosed with ovarian cancer faces a 49% chance of surviving the next five years. Despite this, research in ovarian cancer persists to be disproportionately low in comparison to other fields of oncology.

May 8, 2023

Cancer23

New method accurately analyses genomics data in cancer archival biopsies

A new paper from University of Helsinki, suggests a method for accurately analysing genomics data in cancer archival biopsies.

Sep 6, 2022

Cancer23

Mayo Clinic Uses Genomic Sequencing and AI to Predict Treatment Response

With genomic sequencing and artificial intelligence, Mayo Clinic Cancer Center researchers developed an algorithm to predict how patients with gastric cancer will respond to treatment.

Feb 16, 2022

Cancer23

Artificial intelligence in oncology: current applications and future perspectives

The British journal of cancer have published a systematic review into the current applications and future perspectives of Artificial intelligence in oncology.

Nov 26, 2021

Cancer23

Protein discovery for complex congenital disorders and cancers

Discovery on Protein BRD4 Function in Mice Marks Critical Step in Research to Treat Patients with Complex Congenital Disorders and Cancers

Oct 6, 2021

Cancer23

Men should check their genes for prostate cancer risk

Both sexes have the same risk for inherited gene mutations, such as BRCA1/2 and PALB2.

Sep 23, 2021

Cancer23

Message in a Bottle

The potential of mRNA technology goes well beyond COVID into some of our most prevalent diseases, from the flu to heart disease and even cancer.

Sep 20, 2021